deltatrials

Sanofi Clinical Trials

Sponsors / Sanofi

Sanofi is listed as the lead sponsor on 1,386 clinical trials registered with ClinicalTrials.gov. 78 trials are actively recruiting participants, 52 remain active without open enrollment, and 1068 have concluded. 167 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include safety concerns, slow or insufficient recruitment. The cumulative planned enrollment figure across all listed trials is 2,096,972 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.

1,386
Total Trials
78
Recruiting
52
Other Active
1,068
Completed
167
Terminated / Withdrawn
2,096,972
Total Enrollment

Termination reasons: Safety29% · Other23% · Recruitment22% · Business12% · Efficacy8% · Regulatory2% · Funding2%

Recent Terminations

  • NCT06118099 Phase PHASE2 Stopped Oct 2025
    Hidradenitis
    "Sponsor decision; the decision is not related to any safety concern"
  • NCT06530030 Stopped Sep 2025
    Hemophilia A
    "Early discontinuation based on sponsor decision not driven by any safety concerns."
  • NCT06508489 Phase PHASE1/PHASE2 Stopped Aug 2025
    Acute Myeloid Leukemia
    "Early discontinuation based on strategic sponsor decision not driven by any safety concerns"
  • NCT05839626 Phase PHASE1/PHASE2 Stopped May 2025
    Amyloid Light-chain Amyloidosis
    "Early discontinuation based on sponsor decision not driven by any safety concerns."
  • NCT06067425 Phase PHASE2 Stopped Feb 2025
    Osteochondrodysplasia
    "Sponsor decision. Not related to safety concern."
  • NCT05630547 Phase PHASE2 Stopped Nov 2024
    Multiple Sclerosis
    "The study was terminated as it did not meet its primary and key secondary endpoints"
  • NCT05712278 Phase PHASE1 Stopped Mar 2024
    Acute Myeloid Leukaemia
  • NCT05819125 Stopped Dec 2023
    Venous Thromboembolism
    "Sponsor's decision. Termination decision unrelated to safety profile."
  • NCT05819112 Stopped Dec 2023
    Venous Thromboembolism
    "Sponsor's decision. Termination decision unrelated to safety profile."
  • NCT05552859 Phase PHASE4 Stopped Aug 2023
    Renal Impairment
    "Sponsor decision to cancel trial due to poor recruitment/ severe recruitment delay and not related to safety concern."

Active Trials (52 total)

See all 52 active trials

Top Conditions

Top Locations